Combination therapy consisting of gemcitabine, carboplatin, and docetaxel as an active treatment for advanced urothelial carcinoma. - Wikidata - awgldk - TriplyDB

Combination therapy consisting of gemcitabine, carboplatin, and docetaxel as an active treatment for advanced urothelial carcinoma.

Combination therapy consisting of gemcitabine, carboplatin, and docetaxel as an active treatment for advanced urothelial carcinoma.

http://www.wikidata.org/entity/Q33394627

about

Comparison of single agent versus combined chemotherapy in previously treated patients with advanced urothelial carcinoma: a meta-analysis.Carboplatin-based combination chemotherapy for elderly patients with advanced bladder cancer.

P2860

Q33431220-79C2EDD8-3E9A-4FD9-9051-935093435EE9 Q54770311-5CAE0BD1-2D53-4A96-BF67-21B2A0339E0E

P2860

Combination therapy consisting of gemcitabine, carboplatin, and docetaxel as an active treatment for advanced urothelial carcinoma.

http://www.wikidata.org/entity/Q33394627

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Combination therapy consisting ...... advanced urothelial carcinoma.

@ast

Combination therapy consisting ...... advanced urothelial carcinoma.

@en

type

label

Combination therapy consisting ...... advanced urothelial carcinoma.

@ast

Combination therapy consisting ...... advanced urothelial carcinoma.

@en

prefLabel

Combination therapy consisting ...... advanced urothelial carcinoma.

@ast

Combination therapy consisting ...... advanced urothelial carcinoma.

@en

P1433

Q33394627-0D81789B-E28F-4981-87D4-331B1BD7E076

P1476

Q33394627-52E5BE7A-EFEE-4F35-965F-80080FEE1761

P2093

Q33394627-05117AE7-FF98-49F0-A032-D32166A76F55

Q33394627-2C342954-17B6-404A-9EFA-601B5054E37E

Q33394627-3C771C7C-DC72-4BAC-97A1-26D924F9522F

Q33394627-5E2C7447-50D0-4211-BA91-45EDD3119B19

Q33394627-62EEC805-3CD8-4E06-A69D-494F00F4B640

Q33394627-6FB82BC8-9F4F-4A51-A1CE-35D142D410D4

Q33394627-7699E5A2-11BF-43E4-9FA7-CE0AA2BF32CF

Q33394627-917DFA73-25A2-41DD-8EE8-BE158CAEE772

Q33394627-A7A7D573-935E-4A9B-BCE1-CBD818AF15E6

Q33394627-D398F245-7CD4-42EA-B84F-4CBA926AB55A

P2860

Q33394627-0A68BC89-A5F1-4E11-9874-D8BB21EFA842

Q33394627-0CCF3A88-6687-405C-97F3-7B1F5CEAD194

Q33394627-231629D6-C0C1-4615-9748-DDBBE9E491E4

Q33394627-33C4D9BF-E135-47C4-8600-52B342199E16

Q33394627-5B1FF234-A3EB-496C-A8DF-9DEE6E335A14

Q33394627-7B1E0B81-EB7F-4C5F-ABCA-84E4F4ED5A4B

Q33394627-7DCFB943-8517-464A-91D2-0F9C4EC1C128

Q33394627-AFF2BD2C-44A2-44DD-8DCC-69C9F2C9A8B4

Q33394627-B1E12612-800E-4FE4-B5EF-A02679C25525

Q33394627-B48C3014-4EDD-4266-AB4B-03C8D42CAF0A

P2888

Q33394627-07938A01-4618-4708-BBA3-CBC052134EF3

P304

Q33394627-0C38A7A2-5CDE-40AB-9B44-A5CFB92578B7

P31

Q33394627-C75E6A83-2B41-4779-999F-9570015EF90C

P356

Q33394627-826976B8-D922-4EBB-A6FE-7D6C8D6E0815

P433

Q33394627-464B25EE-A3A6-4F8A-B283-6719952C8314

P478

Q33394627-3C14FE93-0FBE-41B8-9B02-5DC38DFA9730

P577

Q33394627-58D2D58E-201F-48F6-B425-A3CB7BB37A38

P698

Q33394627-0DC27C62-D2E1-4ADB-B483-6D67411C3F5A

P356

S10147-011-0224-4

P1433

International Journal of Clinical Oncology

P1476

Combination therapy consisting ...... advanced urothelial carcinoma.

@en

P2093

Hiroshi Tsuruta

http://www.w3.org/2001/XMLSchema#string

Kazuyuki Numakura

http://www.w3.org/2001/XMLSchema#string

Mitsuru Saito

http://www.w3.org/2001/XMLSchema#string

Norihiko Tsuchiya

http://www.w3.org/2001/XMLSchema#string

Shigeru Satoh

http://www.w3.org/2001/XMLSchema#string

Shintaro Narita

http://www.w3.org/2001/XMLSchema#string

Shinya Maita

http://www.w3.org/2001/XMLSchema#string

Takamitsu Inoue

http://www.w3.org/2001/XMLSchema#string

Takashi Obara

http://www.w3.org/2001/XMLSchema#string

Tomonori Habuchi

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Paclitaxel Carboplatin chemotherapy as a second-line chemotherapy for advanced platinum resistant urothelial cancer in Japanese cases.

Paclitaxel and carboplatin in patients with metastatic urothelial cancer: results of a phase II trial.

A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Italian Co-operative Group on Bladder Cancer.

Paclitaxel with cisplatin as salvage treatment for patients with previously treated advanced transitional cell carcinoma of the urothelial tract.

Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro

Combination treatment with weekly docetaxel and gemcitabine for advanced non-small-cell lung cancer in elderly patients and patients with poor performance status: results of a Minnie Pearl Cancer Research Network phase II trial.

Phase II trial of gemcitabine and docetaxel in patients with advanced carcinoma of the urothelium: a trial of the Eastern Cooperative Oncology Group.

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.

A feasibility study of carboplatin with fixed dose of gemcitabine in "unfit" patients with advanced bladder cancer.

P2888

s10147-011-0224-4

P304

533-538

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10147-011-0224-4

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21431341

http://www.w3.org/2001/XMLSchema#string